| |
ApoB
|
ApoA1
|
ApoB/ApoA1
|
|---|
|
ORa (95% CI)
|
ORb (95% CI)
|
ORc (95% CI)
|
ORa (95% CI)
|
ORb (95% CI)
|
ORc (95% CI)
|
ORa (95% CI)
|
ORb (95% CI)
|
ORc (95% CI)
|
|---|
|
Men
|
|
SF
|
2.54 (1.94, 3.33)
|
2.04 (1.54, 2.71)
|
1.97 (1.50, 2.62)
|
1.52 (1.18, 1.95)
|
1.22 (0.93, 1.59)
|
1.19 (0.91, 1.55)
|
2.78 (2.12, 3.65)
|
2.08 (1.56, 2.78)
|
2.00 (1.50, 2.66)
|
|
TRF
|
2.11 (1.61, 2.75)
|
2.10 (1.58, 2.78)
|
2.00 (1.50, 2.66)
|
0.99 (0.76, 1.30)
|
0.77 (0.58, 1.03)
|
0.74 (0.56, 0.99)
|
1.93 (1.47, 2.52)
|
1.73 (1.29, 2.30)
|
1.62 (1.21, 2.16)
|
|
sTfR
|
1.27 (0.98, 1.64)
|
1.32 (1.01, 1.72)
|
1.28 (0.97, 1.67)
|
0.74 (0.57, 0.96)
|
0.77 (0.59, 1.00)
|
0.75 (0.57, 0.99)
|
0.93 (0.72, 1.20)
|
0.96 (0.74, 1.26)
|
0.92 (0.70, 1.21)
|
|
Hb
|
2.18 (1.66, 2.87)
|
2.14 (1.59, 2.87)
|
2.04 (1.51, 2.74)
|
1.18 (0.90, 1.55)
|
0.84 (0.62, 1.12)
|
0.81 (0.61, 1.09)
|
1.78 (1.36, 2.35)
|
1.47 (1.09, 1.98)
|
1.39 (1.03, 1.87)
|
|
Women
|
|
SF
|
5.59 (4.17, 7.50)
|
2.27 (1.64, 3.16)
|
2.13 (1.53, 2.97)
|
0.86 (0.67, 1.09)
|
0.97 (0.72, 1.30)
|
0.96 (0.72, 1.29)
|
3.21 (2.46, 4.19)
|
1.49 (1.10, 2.03)
|
1.41 (1.04, 1.92)
|
|
TRF
|
1.10 (0.86, 1.41)
|
1.72 (1.31, 2.25)
|
1.55 (1.18, 2.04)
|
0.93 (0.72, 1.19)
|
0.75 (0.57, 0.97)
|
0.73 (0.56, 0.95)
|
0.99 (0.77, 1.27)
|
1.31 (1.00, 1.71)
|
1.21 (0.92, 1.59)
|
|
sTfR
|
1.12 (0.87, 1.44)
|
1.28 (0.98, 1.68)
|
1.26 (0.96, 1.66)
|
0.72 (0.56, 0.91)
|
0.72 (0.56, 0.92)
|
0.71 (0.55, 0.91)
|
0.79 (0.61, 1.01)
|
0.88 (0.68, 1.15)
|
0.87 (0.67, 1.13)
|
|
Hb
|
1.95 (1.52, 2.50)
|
1.86 (1.42, 2.43)
|
1.71 (1.31, 2.25)
|
0.90 (0.71, 1.15)
|
0.73 (0.56, 0.94)
|
0.70 (0.54, 0.91)
|
1.88 (1.47, 2.41)
|
1.64 (1.26, 2.14)
|
1.55 (1.18, 2.02)
|
- ApoB apolipoprotein B, ApoA1 apolipoprotein A1, OR odds ratio, CI confidence interval, SF serum ferritin, TRF transferrin, sTfR soluble transferrin receptor, Hb hemoglobin
- aOriginal model without any adjustments. bAdjusted for age, nationality, regional area, education level, smoking status, alcohol frequency, physical activity, energy intake, fat% intake, protein% intake, body mass index, waist-to-hip ratio and hypersensitive C-reactive protein. cAdjusted for all the variables in model 2 plus the homeostasis model assessment of insulin resistance. Likelihood ratio Chi-square testing was implemented for models comparison in multivariable logistic regression (P < 0.001)
